Filgrastim rhu G-CSF


  • Composition
    Each prefilled syringe of Filgen contains 300 µg of Filgrastim + excipients.

  • Indications
    - Cancer patients who receive myeloablative chemotherapy.
    - Patients with acute myeloid leukemia (AML) receiving induction or consolidation chemotherapy.
    - Patients undergoing bone marrow transplantation (BMT).
    - Patients undergoing peripheral bone marrow progenitors collection
    - Patients with severe chronic neutropenia (SCN).

  • Contraindications
    Known hypersensitivity to E. coli-derived proteins, to Filgrastim or to any other component of the product.

  • Presentation
    Box containing one prefilled syringe with 1 mL of solution.